This course has expired. View available courses.
Neurology
Time to Act! Hereditary ATTR Amyloidosis Polyneuropathy: Early Diagnosis and Treatment
This 30-minute educational program is designed for community neurologists across Canada. It focuses on the appropriate testing for patients with suspected hereditary transthyretin amyloidosis polyneuropathy (hATTR PN). hATTR PN is a rapidly progressing disease with significant morbidity and poor prognosis that is often misdiagnosed. As many as 40% of patients in non-endemic areas receive multiple misdiagnoses and it can take up to six years or more from the time of symptom onset to diagnosis.
Early diagnosis and prompt treatment can delay progression and significantly increase patients’ quality of life. This practical, interactive eCME is part of a patient identification and education program geared towards applying knowledge about hATTR PN to general neurologists’ everyday practice.
DURATION
30 min
PROFESSION
Physician, Specialist
# OF CREDITS
1
ACCREDITATION
MOC - Section 3
EXPIRY DATE
2024-06-24
This 30-minute educational program is designed for community neurologists across Canada. It focuses on the appropriate testing for patients with suspected hereditary transthyretin amyloidosis polyneuropathy (hATTR PN). hATTR PN is a rapidly progressing disease with significant morbidity and poor prognosis that is often misdiagnosed. As many as 40% of patients in non-endemic areas receive multiple misdiagnoses and it can take up to six years or more from the time of symptom onset to diagnosis.
Early diagnosis and prompt treatment can delay progression and significantly increase patients’ quality of life. This practical, interactive eCME is part of a patient identification and education program geared towards applying knowledge about hATTR PN to general neurologists’ everyday practice.
This program has received an unrestricted educational grant or in-kind support from Alnylam.
Faculty
Steven Baker, MD, MSc, FRCPC
Vera Bril, MSc, MD, FRCPC
Amanda Fiander, MD, FRCPC
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Review the neurological presentation of hereditary transthyretin amyloidosis polyneuropathy (hATTR PN);
- Describe the key assessments that may lead to a diagnosis of hATTR PN;
- Discuss the treatment options specific to polyneuropathy and determine when they are most appropriate for hATTR PN.
Accreditation
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by McMaster University, Continuing Professional Development Office (CPD) for a maximum of 1 MOC Section 3 hour.
#
of credits: 1
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Physician, Specialist
Profession
1
# of credits
Learning Objectives
Upon completion of this continuing education program, participants will be better able to:
- Review the neurological presentation of hereditary transthyretin amyloidosis polyneuropathy (hATTR PN);
- Describe the key assessments that may lead to a diagnosis of hATTR PN;
- Discuss the treatment options specific to polyneuropathy and determine when they are most appropriate for hATTR PN.
MOC - Section 3
ACCREDITATION
Neurology
Learning Category
General
Topic
0
Price
2024-06-24
Expiry Date
CAN-eng
Region/Language
Course Description
This 30-minute educational program is designed for community neurologists across Canada. It focuses on the appropriate testing for patients with suspected hereditary transthyretin amyloidosis polyneuropathy (hATTR PN). hATTR PN is a rapidly progressing disease with significant morbidity and poor prognosis that is often misdiagnosed. As many as 40% of patients in non-endemic areas receive multiple misdiagnoses and it can take up to six years or more from the time of symptom onset to diagnosis.
Early diagnosis and prompt treatment can delay progression and significantly increase patients’ quality of life. This practical, interactive eCME is part of a patient identification and education program geared towards applying knowledge about hATTR PN to general neurologists’ everyday practice.
This program has received an unrestricted educational grant or in-kind support from Alnylam.
Faculty
Steven Baker, MD, MSc, FRCPC
Vera Bril, MSc, MD, FRCPC
Amanda Fiander, MD, FRCPC
Accreditation
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of The Royal College of Physicians & Surgeons of Canada, and approved by McMaster University, Continuing Professional Development Office (CPD) for a maximum of 1 MOC Section 3 hour.
30 min
Duration
0
Price
1
# of credits
